![]() |
ADMA | Adma Biologics, Inc. |
Biological Products (no Diagnostic Substances) |
Book value per $ invested | $ 0.11 |
Leverage | 28.66% |
Market Cap | $ 3.6B |
PE | 17.24 |
Dividend Yield | 0.00% |
Profit | $ 207.7m |
Margin | 43.95% |
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.